Tiziana Life Sciences Ltd
Statements
Income Statement
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | – | – | 0.2 | 0.0 | – | – | 0.0 | 0.1 | – | – | – | -0.1 | – | 0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | – | – | -0.2 | 0.0 | – | – | 0.0 | -0.1 | – | – | – | 0.1 | – | -0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.4 | |
| 1.6 | 2.3 | 0.7 | 1.5 | 2.3 | 1.2 | 2.3 | 1.1 | 2.2 | 1.1 | 2.9 | 13 | 1.5 | 1.8 | 1.8 | – | 1.5 | 1.8 | 0.5 | – | – | 2.8 | 6.0 | – | – | 3.7 | 9.1 | – | 6.8 | 5.5 | 3.3 | 4.2 | 4.8 | 4.8 | 5.2 | 5.2 | 2.7 | 3.2 | 3.2 | 7.0 | 16 | |
| – | – | – | – | 9.9 | – | 0.0 | 1.0 | 26 | 1.1 | 2.3 | 12 | 9.9 | 16 | 11 | – | – | – | 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.6 | 2.4 | 1.1 | 1.1 | 1.9 | 0.9 | 1.8 | 2.2 | 1.9 | 0.9 | 2.3 | 26 | 2.4 | 4.8 | 4.6 | – | 5.3 | 4.5 | 5.1 | – | – | 25 | 21 | – | – | 2.3 | 5.6 | – | 12 | 10.0 | 12 | 15 | 6.2 | 6.2 | 13 | 13 | 9.1 | 8.9 | 8.9 | 12 | 39 | |
| -2.2 | -2.4 | -1.8 | -3.6 | -4.1 | -2.1 | -4.1 | -2.2 | -3.9 | -2.0 | -5.1 | -26 | -3.9 | -4.9 | -4.9 | – | -3.9 | -4.8 | -5.1 | – | – | -25 | -21 | – | – | -5.2 | -5.5 | – | -12 | -10 | -12 | -15 | -6.2 | -6.2 | -13 | -13 | -9.2 | -9.0 | -9.0 | -12 | -39 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.1 | 0.0 | – | – | 0.3 | 0.0 | – | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | – | – | 0.0 | – | |
| -2.2 | -4.0 | -1.8 | -3.6 | -4.1 | -2.1 | -4.1 | -2.2 | -3.9 | -2.0 | -5.1 | -26 | -3.9 | -5.0 | -5.0 | – | -3.9 | -5.2 | -5.0 | – | – | -24 | -17 | – | – | -4.8 | -5.5 | – | -13 | -11 | -8.6 | -11 | -8.6 | -8.6 | -16 | -16 | -8.8 | -5.6 | -5.6 | -13 | -33 | |
| – | 0.0 | 0.0 | 0.0 | -0.7 | -0.4 | -0.7 | -0.7 | -0.8 | -0.4 | -1.0 | -0.7 | -0.3 | -0.3 | -0.3 | -0.3 | -0.3 | -0.6 | -0.3 | -1.1 | -1.1 | -2.2 | – | -1.6 | -1.6 | – | 0.0 | – | – | – | – | – | 0.4 | 0.4 | -6.7 | -6.7 | -1.6 | – | – | – | – | |
| -2.2 | -4.0 | -1.8 | -3.6 | -3.4 | -1.7 | -3.4 | -1.4 | -3.1 | -1.6 | -4.1 | -15 | -3.7 | -4.6 | -4.6 | – | -3.7 | -4.6 | -5.0 | – | – | -21 | -17 | – | – | -3.2 | -5.5 | – | -13 | -11 | -8.6 | -11 | -9.1 | -9.1 | -9.3 | -9.3 | -7.2 | -5.6 | -5.6 | -13 | -31 | |
| -2.2 | -4.0 | -1.8 | -3.6 | -4.1 | -2.1 | -4.1 | – | -3.9 | -2.0 | -5.1 | – | -3.8 | -4.8 | -4.8 | – | -3.8 | -4.5 | -5.1 | – | – | -25 | -21 | – | – | -5.2 | -5.5 | – | -13 | -11 | -8.6 | -11 | -8.6 | -8.6 | -16 | -16 | -8.7 | -5.5 | -5.5 | -12 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.